Find clinical trials for Multiple Sclerosis (MS) in Boston, MA

of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...

This study will evaluate whether ofatumumab is excreted at quantifiable levels and at which concentrations in breast milk of lactating women with RMS...

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

of nasal foralumab in patients with non-active secondary progressive multiple sclerosis (SPMS).The primary objectives that this stu...

intravenous (IV) dose (Part 1), subcutaneous (SC) dose (Part 2), multiple ascending SC doses (Part 3), and multiple-ascending SC do ...

This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis...

This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...

The primary objective of this trial is to evaluate the safety and reactogenicity of mRNA-1195 in participants with multiple sclerosis...

This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...

Given the need for better diagnostic imaging techniques in multiple sclerosis (MS), the study aims to investigate the util...